Endothelium-dependent contractions and endothelial dysfunction in human hypertension.

Department of Internal Medicine, University of Pisa, Pisa, Italy.
British Journal of Pharmacology (Impact Factor: 4.99). 07/2009; 157(4):527-36. DOI: 10.1111/j.1476-5381.2009.00240.x
Source: PubMed

ABSTRACT The endothelium is a crucial regulator of vascular physiology, producing in healthy conditions several substances with a potent antiatherosclerotic properties. Accordingly, the presence of endothelial dysfunction is associated with subclinical atherosclerosis and with an increased future risk of cardiovascular events. A large body of evidence supports the fundamental role of nitric oxide (NO) as the main endothelium-derived relaxing factor. However, in the presence of pathological conditions, such as hypertension, endothelial cells, in response to a number of agents and physical stimuli, become also a source of endothelium-derived contracting factors (EDCFs), including endothelins and angiotensin II and particularly cyclooxygenase-derived prostanoids and superoxide anions. These latter were at first identified as responsible for impaired endothelium-dependent vasodilation in patients with essential hypertension. However, cyclooxygenase-dependent EDCFs production is characteristic of the aging process, and essential hypertension seems to only anticipate the phenomenon. It is worth noting that both in aging and hypertension EDCF production is associated with a parallel decrease in NO availability, suggesting that this substance could be oxygen free radicals themselves. Accordingly, in hypertension both indomethacin, a cyclooxygenase inhibitor, and vitamin C, an antioxidant, increase the vasodilation to acetylcholine by restoring NO availability. In conclusion, hypertension is characterized by a decline in endothelial function, associated with a progressive decrease in NO bioavailability and increase in the production of EDCF. The mechanisms that regulate the balance between NO and EDCF, and the processes transforming the endothelium from a protective organ to a source of vasoconstrictor, proaggregatory and promitogenic mediators remain to be determined.

  • [Show abstract] [Hide abstract]
    ABSTRACT: OXYS rats represent a selection strain of laboratory animals, which are characterized by the accelerated senescence. Substantial morphologic changes of cerebral vessels were revealed in the senescence-accelerated OXYS rats by the noninvasive MRI diagnostics using the induced arterial hypertension and the author’s original methods. These changes appeared as vascular lesions with a thickening of the intimae and the increasing of the signal intensity from blood in cerebral vessels. Cerebral arterial hypertension in normotensive Wistar rats developed as result of intraperitoneal injections of hydrocortisone acetate and diet enriched by sodium ions. The pathology of cerebral vessels in OXYS rats began its development much earlier and was based on spontaneous hypertension in connection with initially elevated blood pressure as well as the genotype of the animals. Four different inductors (two vasodilators and two vasoconstrictors) were used in the study of the endothelium-independent and endothelium-dependent vasodilatation and vasoconstrictions. We have compared previously unknown effects of these inductors on cerebral vessels in senescence-accelerated OXYS rats and those in normal Wistar rats. The response of the arteries to the action of inductors showed changes in the status of anterior, middle, and posterior cerebral arteries of circle Willis. Thus, we have indicated the changes in compensatory and adaptive characters of arteries in hypertensive OXYS rats in comparison with hypertensive Wistar rats. Reduced vasodilator response in the middle cerebral arteries suggests an elevated risk for development of arterial hypertension in these rats.
    Applied Magnetic Resonance 06/2014; 45(6):527-536. DOI:10.1007/s00723-014-0538-2 · 1.15 Impact Factor
  • Frontiers in Bioscience 01/2011; 16(1):486. DOI:10.2741/3700 · 4.25 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Angiotensin II is a key player in the pathogenesis of renovascular hypertension, a condition associated with endothelial dysfunction. We investigated aliskiren (ALSK) and L-arginine treatment both alone and in combination on blood pressure (BP), and vascular reactivity in aortic rings. Hypertension was induced in 40 male Wistar rats by clipping the left renal artery. Animals were divided into Sham, 2-kidney, 1-clip (2K1C) hypertension, 2K1C+ALSK (ALSK), 2K1C+L-arginine (L-arg), and 2K1C+ALSK+L-arginine (ALSK+L-arg) treatment groups. For 4 weeks, BP was monitored and endothelium-dependent and independent vasoconstriction and relaxation were assessed in aortic rings. ALSK+L-arg reduced BP and the contractile response to phenylephrine and improved acetylcholine relaxation. Endothelium removal and incubation with N-nitro-L-arginine methyl ester (L-NAME) increased the response to phenylephrine in all groups, but the effect was greater in the ALSK+L-arg group. Losartan reduced the contractile response in all groups, apocynin reduced the contractile response in the 2K1C, ALSK and ALSK+L-arg groups, and incubation with superoxide dismutase reduced the phenylephrine response in the 2K1C and ALSK groups. eNOS expression increased in the 2K1C and L-arg groups, and iNOS was increased significantly only in the 2K1C group compared with other groups. AT1 expression increased in the 2K1C compared with the Sham, ALSK and ALSK+L-arg groups, AT2 expression increased in the ALSK+L-arg group compared with the Sham and L-arg groups, and gp91phox decreased in the ALSK+L-arg group compared with the 2K1C and ALSK groups. In conclusion, combined ALSK+L-arg was effective in reducing BP and preventing endothelial dysfunction in aortic rings of 2K1C hypertensive rats. The responsible mechanisms appear to be related to the modulation of the local renin-angiotensin system, which is associated with a reduction in endothelial oxidative stress.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.] 10/2014; DOI:10.1590/1414-431X20144191 · 1.08 Impact Factor

Full-text (2 Sources)

Available from
May 26, 2014